Catherine Matthews to Postoperative Complications
This is a "connection" page, showing publications Catherine Matthews has written about Postoperative Complications.
Connection Strength
1.588
-
Schachar JS, Ossin D, Plair AR, Hurtado EA, Parker-Autry C, Badlani G, Davila GW, Matthews CA. Optimal timing of a second postoperative voiding trial in women with incomplete bladder emptying after vaginal reconstructive surgery: a randomized trial. Am J Obstet Gynecol. 2020 08; 223(2):260.e1-260.e9.
Score: 0.494
-
Matthews CA. Minimally Invasive Sacrocolpopexy: How to Avoid Short- and Long-Term Complications. Curr Urol Rep. 2016 Nov; 17(11):81.
Score: 0.386
-
Crane AK, Geller EJ, Sullivan S, Robinson BL, Myers EM, Horton C, Matthews CA. Short-term mesh exposure after robotic sacrocolpopexy with and without concomitant hysterectomy. South Med J. 2014 Oct; 107(10):603-6.
Score: 0.334
-
Caveney M, Matthews C, Mirzazadeh M. The Effect of Resident Involvement in Pelvic Prolapse Surgery: A Retrospective Study From a Nationwide Inpatient Sample. Female Pelvic Med Reconstr Surg. 2017 Nov/Dec; 23(6):387-391.
Score: 0.103
-
Gutman RE, Rardin CR, Sokol ER, Matthews C, Park AJ, Iglesia CB, Geoffrion R, Sokol AI, Karram M, Cundiff GW, Blomquist JL, Barber MD. Vaginal and laparoscopic mesh hysteropexy for uterovaginal prolapse: a parallel cohort study. Am J Obstet Gynecol. 2017 Jan; 216(1):38.e1-38.e11.
Score: 0.095
-
Myers EM, Geller EJ, Connolly A, Bowling JM, Matthews CA. Robotic sacrocolpopexy performance and cumulative summation analysis. Female Pelvic Med Reconstr Surg. 2014 Mar-Apr; 20(2):83-6.
Score: 0.080
-
Matthews CA, Carroll A, Hill A, Ramakrishnan V, Gill EJ. Prospective evaluation of surgical outcomes of robot-assisted sacrocolpopexy and sacrocervicopexy for the management of apical pelvic support defects. South Med J. 2012 May; 105(5):274-8.
Score: 0.071
-
Caveney M, Haddad D, Matthews C, Badlani G, Mirzazadeh M. Short-term complications associated with the use of transvaginal mesh in pelvic floor reconstructive surgery: Results from a multi-institutional prospectively maintained dataset. Neurourol Urodyn. 2017 Nov; 36(8):2044-2048.
Score: 0.025